Abstract
Within this dissertation we discussed which differences exist in the three clinical phenotypes of rheumatoid arthritis (RA), namely undifferentiated arthritis (UA), autoantibody-negative RA (RA-) and autoantibody-positive RA (RA+), with a focus on clinical as well as patient-relevant outcomes. We also explored if treatment could be stratified on these clinical phenotypes from a clinical as well as an economic point of view.
Original language | English |
---|---|
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 30 Aug 2022 |
Place of Publication | Rotterdam |
Publication status | Published - 30 Aug 2022 |